Results 121 to 130 of about 43,066 (260)

Systematic review and meta‐analysis of lifestyle modification interventions and their impact on seizure reduction and quality of life

Epilepsia, EarlyView.
Abstract Objective This study was undertaken to provide an overview of the research landscape and evaluate the impact of lifestyle modifications on seizure reduction and quality of life in people with epilepsy receiving standard medical treatment. Methods Following PRISMA (Preferred Reporting Items for Systematic Reviews and Meta‐Analyses) guidelines ...
Elizabeth Spurgeon, Alina Ivanuik, Shivanee Sodani, Elizabeth Butler, David Martinez, Mary Schleicher, Spence Sylvester, Robert Saper, Imad Najm, Dennis Lal   +9 more
wiley   +1 more source

Effects of Low-Carbohydrate and Ketogenic Diets on Anaerobic Performance in Competitive Athletes: A Systematic Review and Meta-Analysis. [PDF]

Nutrients
Gawelczyk M, Chycki J, Maszczyk A, Zając A.   +3 more
europepmc   +1 more source

Intermittent fasting with medium‐chain triglycerides in drug‐resistant epilepsy: A pilot crossover trial

Epilepsia, EarlyView.
Abstract Objective Ketogenic dietary therapies can reduce seizure frequency in drug‐resistant epilepsy, but adherence to the classical ketogenic diet is often poor. Intermittent fasting supplemented with medium‐chain triglycerides (MCTs) may offer a more feasible and less restrictive alternative.
Wiebke Hahn, Emily Falk, Ayla Balzter, Tobias Foer, Shanin Maierhofer, Sophia Jaumann, Sascha Strehlau, Leona Möller, Panagiota‐Eleni Tsalouchidou, Katja Menzler, Lars Timmermann, Susanne Knake   +11 more
wiley   +1 more source

Ketogenic diet for infantile epileptic spasms

Epilepsia Open, EarlyView.
Abstract Approximately half of all cases of Infantile Epileptic Spasms Syndrome (IESS) do not respond to vigabatrin and hormonal therapies. There is no clear consensus as to the second‐line therapy for IESS. Ketogenic diet (KD) has emerged as an effective treatment for certain drug‐resistant epilepsies and in many cases of IESS.
Morris H. Scantlebury, Anamika Choudhary, Andy Cheuk‐Him Ng, Cezar Gavrilovici   +3 more
wiley   +1 more source

The Influence of Short-Term, Severe Low Energy Availability With Varying Protein Content on Substrate Metabolism, High-Intensity Exercise Performance and Subjective Responses in Young Adults. [PDF]

Eur J Sport Sci
Reina BA, Pinto RS, Esteves GP, Mariano JV, Swinton P, Dolan E.   +5 more
europepmc   +1 more source

Ultra‐Processed Food Intake and its Association With Eating Disorders: A Scoping Review

European Eating Disorders Review, EarlyView.
ABSTRACT Objective Ultra‐processed foods have been associated with adverse health outcomes, but their relationship with eating disorders remains unclear. This scoping review mapped the available evidence on the association between ultra‐processed food intake and eating disorders in adolescents and adults.
Marthina Streda Walker, Natália R. Figueiredo, Luana Cristina Lermen, Maria Laura da Costa Louzada, Ana Maria P. Feoli   +4 more
wiley   +1 more source

Greater reduction in the proinsulin-C-peptide ratio with a ketogenic vs control diet in patients with type 2 diabetes. [PDF]

J Endocr Soc
Yurchishin ML, Finn AR, Fowler LA, Vere-Whiting SL, Gower BA.   +4 more
europepmc   +1 more source

Eating Disorder Clinician Views About the Impact of Out‐of‐Home Calorie Labelling on Their Patients: A Qualitative Interview Study

European Eating Disorders Review, EarlyView.
ABSTRACT Objective Accumulating evidence suggests that people with eating disorders experience mainly negative impacts of out‐of‐home calorie labelling. This study explored eating disorder clinician perspectives on how such labels affect individuals with eating disorders, and their views on implementation of this policy.
Abinaya Nadarajah, Imogen Peebles, Fiona Duffy, Nora Trompeter, Ellen Maloney, Dasha Nicholls, Ulrike Schmidt, Lucy Serpell, Helen Sharpe, Tom Jewell   +9 more
wiley   +1 more source

The effects of ketogenic diet and calorie-restricted diet on metabolic dysfunction-associated steatotic liver disease: a retrospective study. [PDF]

Front Nutr
Sun WJ, Xing LL, Zhao SF, Ying HM.
europepmc   +1 more source

Short‐term clinical responses in horses and ponies treated with canagliflozin: A clinical field study

Equine Veterinary Journal, EarlyView.
Abstract Background Treatment with the sodium‐glucose co‐transporter 2 (SGLT2) inhibitor canagliflozin in insulin dysregulated (ID) horses has shown promising results in randomised clinical trials. Larger field studies are needed to further evaluate treatment responses and potential adverse effects under real‐world conditions.
Moa Hällbom, Sanna Truelsen Lindåse, Monika Wartel, Johan Bröjer   +3 more
wiley   +1 more source